Last updated: September 8, 2025
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Anal pap smear and oral swab for cytology and HPV testing
Clinical Study ID
NCT05911750
IIBSP-VHP-2023-47
Ages 18-79 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnosed Crohn's disease or ulcerative colitis (at least 3 months beforeenrollment)
Male
Age from 18 to 79 years
Exclusion
Exclusion Criteria:
Unclassified Inflammatory Bowel Disease
Diarrhea (> 3 bowel movements/day) with rectal bleeding at enrollment
Prior full proctectomy
Inability to collect the biological samples
Inability to complete the questionnaire
Refusal to sign the informed consent
Study Design
Total Participants: 384
Treatment Group(s): 1
Primary Treatment: Anal pap smear and oral swab for cytology and HPV testing
Phase:
Study Start date:
February 12, 2023
Estimated Completion Date:
June 01, 2026
Study Description
Connect with a study center
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Barcelona,
SpainSite Not Available
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Barcelona 3128760,
SpainActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.